The Austin Hospital is a public teaching hospital in Melbourne's north-eastern suburb of Heidelberg, and is administered by Austin Health, along with the Heidelberg Repatriation Hospital and the Royal Talbot Rehabilitation Centre.

There are 671 beds in Austin Health.

During the past decade, Austin Health conducted 242 clinical trials. In the 10-year time frame, 242 clinical trials started and 72 clinical trials were completed, i.e. on average, 29.8% percent of trials that started reached the finish line to date. In the past 5 years, 97 clinical trials started and 38 clinical trials were completed. i.e. 39.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Health" #1 sponsor was "Austin Health" with 32 trials, followed by "Gilead Sciences" with 19 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 14 trials sponsored, "Pfizer" with 14 trials sponsored and "University of Melbourne" with 14 trials sponsored. Other sponsors include 299 different institutions and companies that sponsored additional 171 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Health" #1 collaborator was "National Health and Medical Research Council, Australia" with 19 trials as a collaborator, "Austin Health" with 12 trials as a collaborator, "Merck Sharp & Dohme LLC" with 10 trials as a collaborator, "Bristol-Myers Squibb" with 9 trials as a collaborator and "Austin Hospital, Melbourne Australia" with 8 trials as a collaborator. Other collaborators include 366 different institutions and companies that were collaborators in the rest 242 trials.

According to Clinical.Site data, the most researched conditions in "Austin Health" are "Breast Cancer" (11 trials), "Non-Small Cell Lung Cancer" (11 trials), "Prostate Cancer" (9 trials), "Critical Illness" (7 trials) and "Epilepsy" (7 trials). Many other conditions were trialed in "Austin Health" in a lesser frequency.

Most popular intervention types in "Austin Health" are "Drug" (293 trials), "Other" (53 trials), "Biological" (29 trials), "Device" (22 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (90 trials), "Nivolumab" (12 trials), "Pembrolizumab" (12 trials), "Paclitaxel" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Austin Health" are 363 trials for "All" genders, 20 trials for "Male" genders and 11 trials for "Female" genders.

Currently, there are 161 active trials in "Austin Health". 2 are not yet recruiting, 99 are recruiting, 57 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 171 completed trials in Austin Health, undefined suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Health, 59 "Phase 1" clinical trials were conducted, 124 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 49 trials that are defined as “Not Applicable".

Austin Health has several departments that took part in Clinical trials: "Austin Hospital; Medical Oncology" - 8 trials, "Austin Health; Cancer Clinical Trial Centre" - 7 trials, "Austin Hospital; Department of Neurology" - 5 trials, "Austin and Repatriation Medical Centre; Cancer Services" - 4 trials, "Austin Health (Ludwig Institute Oncology Unit)" - 3 trials, "Victorian Spinal Cord Injury Service, Royal Talbot Rehabilitation Centre" - 2 trials